BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:45 PM
 | 
Oct 21, 2009
 |  BC Extra  |  Company News

Shire's Replagal to be available to Fabry's patients

FDA approved a treatment protocol to provide patient access to Replagal agalsidase alfa from Shire plc (LSE:SHP; NASDAQ:SHPGY). The move is designed to help manage...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >